prnewswire.com
Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2025 Earnings
/CNW/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the
Oppenheimer Holdings Inc.OPYNYSE
LOADING
|||
Latest News
prnewswire.com
Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2025 Earnings
NEW YORK, Jan. 30, 2026 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the fourth quarter of 2025 compared with net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024, an increase of 593.1%. Revenue for the fourth quarter of 2025 was $472.6 million compared to revenue of $375.4 million for the fourth quarter of 2024, an increase of 25.9%.
prnewswire.com
M-tron Industries, Inc. to Host 1x1 Investor Meetings at the Oppenheimer 11th Annual Emerging Growth Conference on February 3, 2026
ORLANDO, Fla., Jan. 28, 2026 /PRNewswire/ -- M-tron Industries, Inc. (NYSE American: MPTI) ("Mtron" or the "Company") is pleased to announce that Cameron Pforr, Chief Executive Officer, and other members of management will host virtual 1x1 meetings with investors at the Oppenheimer 11th Annual Emerging Growth Conference on Tuesday February 3, 2026.
businesswire.com
InTest Corporation to Participate in the Oppenheimer 11th Annual Emerging Growth Conference
MT. LAUREL, N.J.--(BUSINESS WIRE)--InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor (“semi”), automotive/EV, defense/aerospace, industrial, life sciences, and safety/security, today announced that Nick Grant, President & CEO, and Duncan Gilmour, Chief Financial Officer, will host virtual investor meetings at the Oppenheimer 11th Annual Emergin.
seekingalpha.com
Oppenheimer Upgrade Fuels Relay Therapeutics Rally On Zovegalisib Optimism
Relay Therapeutics is upgraded to Outperform with a $14 price target, driven by optimism for zovegalisib in PIK3CA-mutant HR+/HER2- metastatic breast cancer. Zovegalisib's mutant-selective PI3Kα inhibition offers a differentiated safety and efficacy profile versus broader PI3K inhibitors, targeting a large, underserved patient population. RLAY's $596M cash position funds operations into 2029, supporting ongoing pivotal Phase 3 and expansion studies across oncology and vascular malformations.
globenewswire.com
eGain to Participate in the Oppenheimer Emerging Growth Conference on February 4, 2026
SUNNYVALE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- eGain (NASDAQ: EGAN), a leading provider of AI-powered knowledge management and customer experience solutions, today announced that CEO Ashu Roy and CFO Eric Smit will be hosting virtual one-on-one meetings with institutional investors at the Oppenheimer 8th Annual Emerging Growth Conference on Wednesday, February 4, 2026.
accessnewswire.com
Aehr Test Systems to Participate in the 11th Annual Oppenheimer Emerging Growth Conference on February 3, 2026
FREMONT, CA / ACCESS Newswire / January 27, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), data center, automotive, and industrial applications, today announced it will participate in the Oppenheimer 11th Annual Emerging Growth Conference being held virtually February 3-4, 2026. Aehr Test CEO Gayn Erickson and CFO Chris Siuwill be hosting virtual meetings with investors throughout the day on Tuesday, February 3rd.
businesswire.com
Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference.
prnewswire.com
American Public Education, Inc. to Participate in The Oppenheimer 11th Annual Emerging Growth Conference
CHARLES TOWN, W.Va., Jan. 20, 2026 /PRNewswire/ -- American Public Education, Inc. (the "Company") (Nasdaq: APEI), a company which transforms lives, advances careers and improves communities by providing online and campus-based postsecondary education to approximately 109,000 students, today announced that Angela Selden, President & Chief Executive Officer, Edward Codispoti, Chief Financial Officer, and Gary Janson, SVP Strategy & Growth will participate in the Oppenheimer 11th Annual Emerging Growth Conference, taking place virtually on Tuesday & Wednesday, February 3-4, 2026.
youtube.com
John Stoltzfus of Oppenheimer sees S&P 500 at 8,100 by end-2026
John Stoltzfus, Chief Investment Strategist at Oppenheimer Asset Management, outlines an 8,100 S&P 500 target for 2026, remains overweight US equities, selective in fixed income, with modest gold exposure.
defenseworld.net
Oppenheimer (NYSE:OPY) Share Price Passes Above 200-Day Moving Average – What’s Next?
Oppenheimer Holdings, Inc. (NYSE: OPY - Get Free Report)'s share price crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $70.43 and traded as high as $74.64. Oppenheimer shares last traded at $73.3660, with a volume of 31,128 shares changing hands. Wall Street Analyst Weigh In
gurufocus.com
Market Today: Metals Rally; Nvidia-Groq Deal Lifts NVDA
Stock News Metals surge as stocks hold near records: Gold and silver hit fresh records while major U.S. indexes closed little changed; mining shares including F
youtube.com
Oppenheimer's Brian Nagel shares his bull case for Nike
Oppenheimer's Brian Nagel joins 'Fast Money' to talk why he believes the slump in Nike shares could be a buying opportunity.
defenseworld.net
Oppenheimer (NYSE:OPY) Sees Unusually-High Trading Volume After Dividend Announcement
Shares of Oppenheimer Holdings, Inc. (NYSE: OPY - Get Free Report) saw unusually-high trading volume on Monday following a dividend announcement from the company. Approximately 51,888 shares changed hands during mid-day trading, an increase of 41% from the previous session's volume of 36,907 shares.The stock last traded at $74.2350 and had previously closed at $72.57. The
prnewswire.com
OPPENHEIMER HOLDINGS INC. DECLARES SPECIAL DIVIDEND
NEW YORK , Dec. 12, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) today announced that its Board of Directors has declared a special cash dividend on OPY Class A non-voting and Class B voting common stock of $1.00 per share, payable January 9, 2026, to shareholders of record as of the close of business on December 26, 2025. The aggregate payment will be approximately $10.5 million.
prnewswire.com
Oppenheimer & Co. Inc. Strengthens Equities and Biotech Research Teams with Addition of Kostas Biliouris, Ph.D.
The addition of well-respected biotech expert strengthens one of Oppenheimer's longest-standing franchise areas NEW YORK , Dec. 8, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE: OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on its Biotech Research Team. He will report to William (Bill) Bird, Director of Research, and be based in New York City.
defenseworld.net
Comparing Moelis & Company (NYSE:MC) and Oppenheimer (NYSE:OPY)
Oppenheimer (NYSE: OPY - Get Free Report) and Moelis and Company (NYSE: MC - Get Free Report) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, profitability, institutional ownership, risk, dividends and earnings. Insider and Institutional Ownership 32.3% of Oppenheimer shares
defenseworld.net
Oppenheimer Holdings, Inc. $OPY Shares Purchased by American Century Companies Inc.
American Century Companies Inc. raised its holdings in Oppenheimer Holdings, Inc. (NYSE: OPY) by 12.2% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 255,066 shares of the financial services provider's stock after purchasing an additional 27,677 shares during
proactiveinvestors.com
Amazon's cloud capacity expansion signals potential revenue upside through 2027, says Oppenheimer
Amazon.com Inc (NASDAQ:AMZN) could see meaningful revenue upside over the next two years as its cloud computing arm, Amazon Web Services (AWS), continues to unlock capacity, according to Oppenheimer analysts. In a note Monday, Oppenheimer raised its price target on Amazon to $305 from $290 while reiterating an “Outperform” rating.
globenewswire.com
Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit
TEL AVIV, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that co-founder and CEO Adi Mor, PhD, will participate in Oppenheimer's Movers in Rare Disease Summit on Thursday, December 11, 2025, at the Sofitel Hotel in New York City.